Published in Hepatitis Weekly, January 24th, 2005
According to researchers in the United States, the "heterogeneous nature" of human HCC "has hampered both treatment and prognostic predictions."
In a study conducted by J.S. Lee and coauthors at the National Cancer Institute, "[g]ene expression profiles of human HCC were analyzed to define the molecular characteristics of the tumors and to test the prognostic value of the expression profiles."
"By applying global gene expression analyses, including unsupervised and supervised methods, two distinctive subclasses of HCC that were...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.